AAAAAA
Results: 1-25/30
Authors:
RAGDE H
BLASKO JC
GRIMM PD
KENNY GM
SYLVESTER J
HOAK DC
CAVANAGH W
LANDIN K
Citation: H. Ragde et al., BRACHYTHERAPY FOR CLINICALLY LOCALIZED PROSTATE-CANCER (VOL 13, PG 438, 1997), Seminars in surgical oncology, 14(2), 1998, pp. 185-185
Authors:
SALGALLER ML
TJOA BA
LODGE PA
RAGDE H
KENNY G
BOYNTON A
MURPHY GP
Citation: Ml. Salgaller et al., DENDRITIC CELL-BASED IMMUNOTHERAPY OF PROSTATE-CANCER, Critical reviews in immunology, 18(1-2), 1998, pp. 109-119
Authors:
BARREN RJ
HOLMES EH
BOYNTON AL
GREGORAKIS A
ELGAMAL AAA
COBB OE
WILSON CL
RAGDE H
MURPHY GP
Citation: Rj. Barren et al., METHOD FOR IDENTIFYING PROSTATE CELLS IN SEMEN USING FLOW-CYTOMETRY, The Prostate, 36(3), 1998, pp. 181-188
Authors:
TJOA BA
SIMMONS SJ
BOWES VA
RAGDE H
ROGERS M
ELGAMAL A
KENNY GM
COBB OE
IRETON RC
TROYCHAK MJ
SALGALLER ML
BOYNTON AL
MURPHY GP
Citation: Ba. Tjoa et al., EVALUATION OF PHASE I II CLINICAL-TRIALS IN PROSTATE-CANCER WITH DENDRITIC CELLS AND PSMA PEPTIDES/, The Prostate, 36(1), 1998, pp. 39-44
Authors:
SALGALLER ML
LODGE PA
MCLEAN JG
TJOA BA
LOFTUS DJ
RAGDE H
KENNY GM
ROGERS M
BOYNTON AL
MURPHY GP
Citation: Ml. Salgaller et al., REPORT OF IMMUNE MONITORING OF PROSTATE-CANCER PATIENTS UNDERGOING T-CELL THERAPY USING DENDRITIC CELLS PULSED WITH HLA-A2-SPECIFIC PEPTIDES FROM PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA), The Prostate, 35(2), 1998, pp. 144-151
MEASUREMENT OF SERUM PROSTATE-SPECIFIC MEMBRANE ANTIGEN, A NEW PROGNOSTIC MARKER FOR PROSTATE-CANCER
Authors:
MURPHY GP
KENNY GM
RAGDE H
WOLFERT RL
BOYNTON AL
HOLMES EH
MISROCK SL
BARTSCH G
KLOCKER H
POINTNER J
REISSIGL A
MCLEOD DG
DOUGLAS T
MORGAN T
GILBAUGH J
Citation: Gp. Murphy et al., MEASUREMENT OF SERUM PROSTATE-SPECIFIC MEMBRANE ANTIGEN, A NEW PROGNOSTIC MARKER FOR PROSTATE-CANCER, Urology, 51, 1998, pp. 89-97
Authors:
RAGDE H
BLASKO J
GRIMM P
KENNY G
SYLVESTER J
LANDIN K
Citation: H. Ragde et al., 3 YEAR OBSERVED BIOCHEMICAL DISEASE-FREE SURVIVAL IN T1 T2 PROSTATE-CANCER PATIENTS TREATED WITH BRACHYTHERAPY/, The Journal of urology, 159(5), 1998, pp. 237-237
Authors:
RAGDE H
ELGAMAL AAA
SNOW PB
BRANDT J
BARTOLUCCI AA
NADIR BS
KORB LJ
Citation: H. Ragde et al., 10-YEAR DISEASE-FREE SURVIVAL AFTER TRANSPERINEAL SONOGRAPHY-GUIDED I-125 BRACHYTHERAPY WITH OR WITHOUT 45-GRAY EXTERNAL-BEAM IRRADIATION IN THE TREATMENT OF PATIENTS WITH CLINICALLY LOCALIZED, LOW TO HIGH GLEASON GRADE PROSTATE CARCINOMA, Cancer, 83(5), 1998, pp. 989-1001
Authors:
RAGDE H
Citation: H. Ragde, PROSTATE-CANCER BRACHYTHERAPY, Seminars in surgical oncology, 13(6), 1997, pp. 389-390
Authors:
RAGDE H
BLASKO JC
GRIMM PD
KENNY GM
SYLVESTER J
HOAK DC
CAVANAGH W
LANDIN K
Citation: H. Ragde et al., BRACHYTHERAPY FOR CLINICALLY LOCALIZED PROSTATE-CANCER - RESULTS AT 7-YEAR AND 8-YEAR FOLLOW-UP, Seminars in surgical oncology, 13(6), 1997, pp. 438-443
Authors:
GRIMM PD
BLASKO J
RAGDE H
SYLVESTER J
CAVANAGH W
Citation: Pd. Grimm et al., TRANSPERINEAL ULTRASOUND-GUIDED I-125 PD-103 BRACHYTHERAPY FOR EARLY-STAGE PROSTATE-CANCER - UPDATE ON CLINICAL-EXPERIENCE AT 7 YEARS/, International journal of radiation oncology, biology, physics, 39(2), 1997, pp. 219-219
Authors:
PRESTIDGE BR
HOAK DC
GRIMM PD
RAGDE H
CAVANAGH W
BLASKO JC
Citation: Br. Prestidge et al., POSTTREATMENT BIOPSY RESULTS FOLLOWING INTERSTITIAL BRACHYTHERAPY IN EARLY-STAGE PROSTATE-CANCER, International journal of radiation oncology, biology, physics, 37(1), 1997, pp. 31-39
Authors:
MURPHY GP
MAGUIRE RT
ROGERS B
PARTIN AW
NELP WB
TROYCHAK MJ
RAGDE H
KENNY GM
BARREN RJ
BOWES VA
GREGORAKIS AK
HOLMES EH
BOYNTON AL
Citation: Gp. Murphy et al., COMPARISON OF SERUM PSMA, PSA LEVELS WITH RESULTS OF CYTOGEN-356 PROSTASCINT(R) SCANNING IN PROSTATIC-CANCER PATIENTS, The Prostate, 33(4), 1997, pp. 281-285
Authors:
MURPHY GP
TROYCHAK MJ
COBB OE
BOWES VA
KENNY RJ
BARREN RJ
KENNY GM
RAGDE H
HOLMES EH
WOLFERT RL
Citation: Gp. Murphy et al., EVALUATION OF PSA, FREE PSA, PSMA, AND TOTAL AND BONE ALKALINE-PHOSPHATASE LEVELS COMPARED TO BONE SCANS IN THE MANAGEMENT OF PATIENTS WITHMETASTATIC PROSTATE-CANCER, The Prostate, 33(2), 1997, pp. 141-146
Authors:
TJOA BA
ERICKSON SJ
BOWES VA
RAGDE H
KENNY GM
COBB OE
IRETON RC
TROYCHAK MJ
BOYNTON AL
MURPHY GP
Citation: Ba. Tjoa et al., FOLLOW-UP EVALUATION OF PROSTATE-CANCER PATIENTS INFUSED WITH AUTOLOGOUS DENDRITIC CELLS PULSED WITH PSMA PEPTIDES, The Prostate, 32(4), 1997, pp. 272-278
Authors:
RAGDE H
KENNY GM
MURPHY GP
LANDIN K
Citation: H. Ragde et al., TRANSRECTAL ULTRASOUND MICROBUBBLE CONTRAST ANGIOGRAPHY OF THE PROSTATE, The Prostate, 32(4), 1997, pp. 279-283
Authors:
SYLVESTER J
BLASKO JC
GRIMM P
RAGDE H
Citation: J. Sylvester et al., INTERSTITIAL IMPLANTATION TECHNIQUES IN PROSTATE-CANCER, Journal of surgical oncology, 66(1), 1997, pp. 65-75
Authors:
RAGDE H
Citation: H. Ragde, BRACHYTHERAPY (SEED IMPLANTATION) FOR CLINICALLY LOCALIZED PROSTATE-CANCER, Journal of surgical oncology, 64(1), 1997, pp. 79-81
Authors:
RAGDE H
BLASKO JC
GRIMM PD
KENNY GM
SYLVESTER JE
HOAK DC
LANDIN K
CAVANAGH W
Citation: H. Ragde et al., INTERSTITIAL I-125 RADIATION WITHOUT ADJUVANT THERAPY IN THE TREATMENT OF CLINICALLY LOCALIZED PROSTATE CARCINOMA, Cancer, 80(3), 1997, pp. 442-453
Authors:
GRIMM PD
BLASKO JC
RAGDE H
SYLVESTER J
CLARKE D
Citation: Pd. Grimm et al., DOES BRACHYTHERAPY HAVE A ROLE IN THE TREATMENT OF PROSTATE-CANCER, Hematology/oncology clinics of North America, 10(3), 1996, pp. 653
Authors:
MURPHY G
TJOA B
RAGDE H
KENNY G
BOYNTON A
Citation: G. Murphy et al., PHASE-I CLINICAL-TRIAL - T-CELL THERAPY FOR PROSTATE-CANCER USING AUTOLOGOUS DENDRITIC CELLS PULSED WITH HLA-A0201-SPECIFIC PEPTIDES FROM PROSTATE-SPECIFIC MEMBRANE ANTIGEN, The Prostate, 29(6), 1996, pp. 371-380
Authors:
MURPHY GP
TINO WT
HOLMES EH
BOYNTON AL
ERICKSON SJ
BOWES VA
BARREN RJ
TJOA BA
MISROCK SL
RAGDE H
KENNY GM
Citation: Gp. Murphy et al., MEASUREMENT OF PROSTATE-SPECIFIC MEMBRANE ANTIGEN IN THE SERUM WITH ANEW ANTIBODY, The Prostate, 28(4), 1996, pp. 266-271
Authors:
TJOA B
BOYNTON A
KENNY G
RAGDE H
MISROCK SL
MURPHY G
Citation: B. Tjoa et al., PRESENTATION OF PROSTATE TUMOR-ANTIGENS BY DENDRITIC CELLS STIMULATEST-CELL PROLIFERATION AND CYTOTOXICITY, The Prostate, 28(1), 1996, pp. 65-69
Authors:
BLASKO JC
RAGDE H
LUSE RW
SYLVESTER JE
CAVANAGH W
GRIMM PD
Citation: Jc. Blasko et al., SHOULD BRACHYTHERAPY BE CONSIDERED A THERAPEUTIC OPTION IN LOCALIZED PROSTATE-CANCER, Urologic clinics of North America, 23(4), 1996, pp. 633
Authors:
MURPHY GP
BARREN RJ
ERICKSON SJ
BOWES VA
WOLFERT RL
BARTSCH G
KLOCKER H
POINTNER J
REISSIGL A
MCLEOD DG
DOUGLAS T
MORGAN T
KENNY GM
RAGDE H
BOYNTON AL
HOLMES EH
Citation: Gp. Murphy et al., EVALUATION AND COMPARISON OF 2 NEW PROSTATE CARCINOMA MARKERS - FREE-PROSTATE SPECIFIC ANTIGEN AND PROSTATE-SPECIFIC MEMBRANE ANTIGEN, Cancer, 78(4), 1996, pp. 809-818